Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download55 - 60 of 232 results
Astrazeneca - A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism and Excretion of Savolitinib in Healthy Male Volunteers
6 June 2023Strategies for Achieving Regulatory Milestones Faster Using Quotient Sciences Translational Pharmaceutics®
19 April 2023Bioanalytical Strategies for Insulin Analogues & Other Large Peptides Using LC-MS
21 February 2023Navigating the Small Molecule CMC Pathway
19 January 2023Astrazeneca - Mass balance recovery and disposition of AZD4831 in humans
13 January 2023The use of electrospraying as a means of drug loading into mesoporous silica particles for enhanced dissolution
5 January 2023Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.